Treatment strategies for metastatic non small-cell lung cancer.
This review article provides evidence to support the use of chemotherapy for non small-cell lung cancer (NSCLC). Chemotherapy plays an important role in the management of advanced NSCLC. Chemotherapy offers symptom palliation, modest but real survival benefits and improves quality of life. The survival benefits achieved with newer drug regimens offer chemotherapy as a strategy for the treatment of NSCLC patients with good performance, no medical or psychological contraindications.